SynthesisBMC endocrine disorders2026
Effects of carbohydrate-modified diets on insulin sensitivity in children and adolescents with overweight/obesity: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt remains unclear whether modifying dietary carbohydrate intake affects insulin concentration and sensitivity in children and adolescents with overweight/obesity. This systematic review and meta-analysis aimed to investigate the effects of carbohydrate modifications on insulin-related outcomes in this population.
methodsA systematic search in PubMed, Scopus, and Web of Science was conducted up to May 18, 2025, without language restrictions. We included randomized clinical trials that investigated the effects of carbohydrate quantity or quality on insulin markers in children and adolescents with overweight/obesity. The risk of bias and the certainty of evidence were assessed. Random-effects meta-analyses were used to estimate weighted mean differences (WMDs) and 95% confidence intervals (CIs) for each outcome.
resultsSeventeen trials were included. Interventions consisted of low-glycemic index (GI) diets and reduced-carbohydrate diets. The pooled analysis showed that compared to control diets, carbohydrate-modified diets—including both low-GI and reduced-carbohydrate diets—showed no significant effect on insulin concentrations but resulted in a significant improvement in the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) (WMD = -0.43, 95% CI = -0.83, -0.03; I² = 48.8%). Low-GI diets also had no significant effects on fasting insulin and HOMA-IR. However, influence analysis demonstrated a significant decrease in HOMA-IR in the low-GI diets after removing a trial conducted among children with obesity and non-alcoholic fatty liver disease (WMD = -0.49, 95% CI = -0.90, -0.07; I2 = 9.9%). Subgroup analyses also indicated that low-GI diets combined with calorie restriction significantly reduced fasting insulin (WMD = -3.05 µIU/mL, 95% CI: -5.22, -0.87; I² = 0%) and HOMA-IR (WMD = -0.65, 95% CI: -1.13, -0.16; I² = 0%). Additionally, low-GI diets with a balanced macronutrient distribution (46–65% of energy) significantly lowered HOMA-IR (WMD = -0.53, 95% CI: -1.00, -0.06; I² = 22.4%). Reduced-carbohydrate diets had no significant effects on fasting insulin or HOMA-IR compared to control diets.
conclusionsThis meta-analysis suggests that in children and adolescents with overweight/obesity, improving carbohydrate quality through a low-GI diet may improve insulin sensitivity. The benefits of low-GI diets were particularly observed when they were implemented alongside calorie restriction or when carbohydrates constituted 45–65% of total energy intake. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.